In summary, the above results are difficult to comment on due to the heterogeneity of the tissues of the CRC itself, significant differences in the amount of tissue tested from patients, the absence of control groups in some studies, and methodological differences (e.g., type and dilutions of anti-SST antibodies, scales for quantifying IHC reactions). The gene discussed is SST; the disease is colorectal carcinoma.